|
Apr 16
|
Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know
|
|
Apr 16
|
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
|
|
Mar 19
|
2 No-Brainer Biotech Stocks to Buy Right Now
|
|
Mar 19
|
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
|
|
Mar 19
|
Vaccine makers face mRNA backlash as states seek further restrictions
|
|
Mar 18
|
Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?
|
|
Mar 17
|
Moderna (MRNA) Advances But Underperforms Market: Key Facts
|
|
Mar 15
|
Down 93%, Is It Finally Time to Buy Moderna?
|
|
Mar 14
|
Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?
|
|
Mar 13
|
Citi says SMid biotechs alternative to large caps as it starts coverage
|
|
Mar 12
|
Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges
|
|
Mar 12
|
3 Reasons MRNA is Risky and 1 Stock to Buy Instead
|
|
Mar 11
|
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
|
|
Mar 10
|
Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges
|
|
Mar 9
|
3 CEOs Just Spent Millions Buying Their Beaten-Down Stock
|
|
Mar 7
|
Why Moderna Stock Has Surged 15% This Week Despite Mixed News
|
|
Mar 7
|
Moderna (NasdaqGS:MRNA) Rises 10% Despite US$1 Billion Revenue Drop Prediction
|
|
Mar 7
|
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
|
|
Mar 6
|
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
|
|
Mar 6
|
Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court
|